Literature DB >> 17090840

Factor V Leiden and prothrombin gene G20210A mutations are uncommon in portal vein thrombosis in India.

Sanjay Sharma1, Sirish I Kumar, Ujjal Poddar, S K Yachha, Rakesh Aggarwal.   

Abstract

BACKGROUND: Extra-hepatic portal vein obstruction due to portal vein thrombosis (PVT) is an important cause of portal hypertension in several regions including India. The cause of thrombosis in these patients remains unclear. We studied the frequency of mutations in genes for coagulation factors V and II (prothrombin) in 61 Indian patients with PVT and 49 healthy control subjects.
METHODS: The presence of factor V Leiden mutation and of G20210A prothrombin gene mutation was determined using polymerase chain reaction followed by restriction fragment length polymorphism. Chi-squared test was used to compare patients and controls.
RESULTS: Of the 61 patients (median age 11 years; 47 male) studied, 49 were children. One of 61 (1.6%) patients with PVT was heterozygous for factor V Leiden mutation and none had the G20210 prothrombin gene mutation. The frequencies of these mutations were not different from those in control subjects (2/49 and 0/46, respectively).
CONCLUSION: Factor V Leiden and G20210 prothrombin gene mutations are infrequent in Indian patients with PVT. Thus, these mutations are unlikely to be responsible for PVT in the Indian population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17090840

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  13 in total

1.  Low frequency of V617F mutation in JAK2 gene in Indian patients with hepatic venous outflow obstruction and extrahepatic portal venous obstruction.

Authors:  Praveer Rai; Pankaj Kumar; Swapnil Mishra; Rakesh Aggarwal
Journal:  Indian J Gastroenterol       Date:  2016-09-16

Review 2.  Portal vein thrombosis.

Authors:  Yogesh K Chawla; Vijay Bodh
Journal:  J Clin Exp Hepatol       Date:  2015-01-06

3.  Procoagulant abnormalities in cirrhosis with portal vein thrombosis.

Authors:  Chhagan Bihari; Priyanka Saxena; Archana Rastogi; Ajeet Singh Bhadoria; Shvetank Sharma; Shiv Kumar Sarin
Journal:  Indian J Gastroenterol       Date:  2014-09

4.  Etiology and long-term outcome of extrahepatic portal vein obstruction in children.

Authors:  Batia Weiss; Eyal Shteyer; Asaf Vivante; Drora Berkowitz; Shimon Reif; Zvi Weizman; Yoram Bujanover; Rivka Shapiro
Journal:  World J Gastroenterol       Date:  2010-10-21       Impact factor: 5.742

5.  Risk factors of thrombosis in abdominal veins.

Authors:  Amit-Kumar Dutta; Ashok Chacko; Biju George; Joseph Anjilivelil Joseph; Sukesh Chandran Nair; Vikram Mathews
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

6.  High incidence of hepatitis B infection-associated cirrhosis and hepatocellular carcinoma in the Southeast Asian patients with portal vein thrombosis.

Authors:  Korn Lertpipopmetha; Chirayu U Auewarakul
Journal:  BMC Gastroenterol       Date:  2011-06-10       Impact factor: 3.067

7.  Splanchnic vein thrombosis in the mediterranean area in children.

Authors:  Hanaa El-Karaksy; Mona El-Raziky
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-07-08       Impact factor: 2.576

8.  Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss.

Authors:  Majid Teremmahi Ardestani; Hossein Hadi Nodushan; Abbas Aflatoonian; Nasrin Ghasemi; Mohammad Hasan Sheikhha
Journal:  Iran J Reprod Med       Date:  2013-01

9.  Pharmacogenetic typing for oral anti-coagulant response among factor V Leiden mutation carriers.

Authors:  Risha Nahar; Renu Saxena; Roumi Deb; Ishwar C Verma
Journal:  Indian J Hum Genet       Date:  2012-09

10.  Management of bleeding in extrahepatic portal venous obstruction.

Authors:  N Chaudhary; S Mehrotra; M Srivastava; S Nundy
Journal:  Int J Hepatol       Date:  2013-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.